Nasal instillation of povidone‐iodine ameliorates ongoing mucosal inflammation in a pre‐sensitized murine model of Der p1‐induced allergic rhinitis

Author:

Kang Jae‐Yoon1,Choi Mi‐Ra1,Kim Yong Min1

Affiliation:

1. Department of Otorhinolaryngology‐Head and Neck Surgery Research Institute for Medical Science Chungnam National University College of Medicine Daejeon South Korea

Abstract

AbstractBackgroundInterleukin (IL)‐33, when cleaved into smaller fragments by proteases, becomes hyperactive, contributing to allergic inflammation. Povidone‐iodine (PVP‐I) is an iodine‐based compound that exhibits antimicrobial properties and inhibits proteases. This study aimed to investigate whether PVP‐I treatment inhibits IL‐33 cleavage, improves allergic rhinitis (AR) symptoms, and suppresses allergic inflammation in a mouse model.MethodsIn vitro experiments using full‐length recombinant human IL‐33 and allergens, including house dust mites or Dermatophagoides pteronyssinus 1, were conducted using western blotting. Fifty BALB/c mice were divided into five groups: control (CON), AR with phosphate‐buffered saline treatment (AR), PVP‐I treatment (AR + PVP), trans‐epoxysuccinyl‐L‐leucylamido(4‐guanidino)butane (E64) treatment (AR + E64), and dexamethasone treatment (AR + Dexa). Nasal symptom scores, including rubbing and sneezing, were measured. The cytokine levels in the nasal lavage fluid (NLF) and the concentration of immunoglobulins in the blood serum were assessed. Nasal mucosa from each group was used for reverse transcriptase‐polymerase chain reaction (RT‐PCR) and histological analyses were conducted.ResultsPVP‐I treatment reduced nasal symptoms, suppressed allergic inflammation, and decreased the levels of IL‐33, IL‐5, and IL‐13 in the NLF and total immunoglobulin E (IgE) and specific IgE in the serum. Histopathological analysis revealed a reduction in the number of eosinophils and goblet cells in the nasal mucosa of the AR + PVP group when compared to the AR group. RT‐PCR and immunofluorescence staining confirmed the downregulation of genes and proteins associated with allergic inflammation.ConclusionsThese findings suggest that nasal irrigation with PVP‐I may be a promising therapeutic option for managing AR by inhibiting IL‐33 activation and suppressing allergic inflammation.

Funder

National Research Foundation of Korea

Chungnam National University

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3